Literature DB >> 2820752

Functional interleukin 2 receptors on B cells lacking Tac antigens.

T Tanaka1, O Saiki, S Doi, M Hatakeyama, T Doi, T Kono, H Mori, M Fujii, K Sugamura, S Negoro.   

Abstract

Human B lymphoblastoid line, SKW 6-4, cells were induced to IgM-secreting cells by high concentrations of interleukin 2 (IL 2). These cells were found to be unreactive with anti-Tac antibody and did not express mRNA detectable for Tac antigen. In Scatchard plot analysis, low-affinity IL 2-binding sites were found on SKW 6-4 cells. Moreover, analysis of the IL 2-binding molecules revealed ones (molecular weight 70,000 and 75,000) distinct from Tac antigen. It is conceivable that IL 2 exerts its effect through its interaction with these novel IL 2-binding molecules in SKW 6-4 cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820752     DOI: 10.1002/eji.1830170925

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Improvement in the antibody productivity of human-human hybridomas by transfection with Tac gene.

Authors:  K Iwamoto; Y Shintani; R Sasada; T Honjo; K Kitano
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

2.  Recombinant human interleukin-2-induced mitogenic proliferation of in vitro unstimulated bovine intestinal lymphocytes.

Authors:  A M Nagi; L A Babiuk
Journal:  Can J Vet Res       Date:  1989-01       Impact factor: 1.310

3.  Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.

Authors:  P Engel; J Inglés; O de la Calle; T Gallart
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

4.  Demonstration of high-affinity interleukin-2 receptors on B-chronic lymphocytic leukemia cells: functional and structural characterization.

Authors:  H Yagura; T Tamaki; T Furitsu; Y Tomiyama; T Nishiura; N Tominaga; S Katagiri; T Yonezawa; S Tarui
Journal:  Blut       Date:  1990-03

Review 5.  Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient.

Authors:  S Doi; O Saiki; T Hara; T Sugita; K Ha-Kawa; T Tanaka; H Hara; S Negoro; H Yabuuchi; S Kishimoto
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

6.  Expression of novel interleukin 2 binding molecules and their functional roles in human B cell differentiation.

Authors:  T Tanaka; O Saiki; S Doi; M Suemura; S Negoro; S Kishimoto
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes.

Authors:  A C Fluckiger; P Garrone; I Durand; J P Galizzi; J Banchereau
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.